Translational Psychiatry, 2023 · DOI: https://doi.org/10.1038/s41398-023-02313-9 · Published: January 6, 2023
This study explores the genetic risk factors for PTSD following mild traumatic brain injury (mTBI). It uses polygenic risk scores (PRS) to assess the genetic liability for PTSD, major depressive disorder (MDD), and neuroticism (NEU). The aim was to determine if these genetic predispositions increase the likelihood of developing PTSD after mTBI. The study found that individuals with a higher PTSD-PRS had a significantly greater risk of developing PTSD after mTBI. This suggests that genetic factors play a role in the development of PTSD following such injuries. The PTSD-PRS was more predictive than MDD-PRS or NEU-PRS. The findings suggest that PRS could potentially be used to identify individuals at higher risk for PTSD after mTBI. This could allow for early intervention and enhanced follow-up, potentially improving outcomes for those at risk. This approach could personalize treatment strategies based on genetic risk.
Polygenic risk scores could be incorporated into risk assessment tools to identify individuals at high risk of developing PTSD after mTBI.
Individuals identified as high-risk based on their PRS could be targeted for early interventions, such as increased monitoring and psychological support.
Further research is needed to validate the clinical utility of PRS in predicting PTSD after mTBI and to explore its potential in diverse populations.